BioWorld

March 1, 2010

View Archived Issues

IPO Activity Poised to Pop with Anthera, Aveo and Trius on Deck

It's been nearly a month since Ironwood Pharmaceuticals Inc. tested the biotech initial public offering waters, and now three more biotechs are queued up to price IPOs over the next three weeks. (BioWorld Today) Read More

HCV Combo Approach Keeping Partner Hopes Bright for Idenix

Read More

'Clear and Testable Hypothesis' on Pediatric Asthma's Roots

Read More

Amicus Adds $18.5M Publicly for Phase III Amigal Program

Read More

Collins: NIH Funding Boosts Economy, Spurs Job Growth

Read More

Move Over, Cerezyme; Shire's Vpriv Gets Official FDA Nod

Read More

Other News To Note

Read More

Vital Signs for March 1, 2010

Read More

Clinic Roundup

Read More

Bench Press

Read More